Marc A. Emerson
YOU?
Author Swipe
View article: Associations between social drivers of health and breast cancer stage at diagnosis among U.S. Black women
Associations between social drivers of health and breast cancer stage at diagnosis among U.S. Black women Open
U.S. Black women have disproportionately high breast cancer mortality, partly due to later-stage diagnoses. We examined how social drivers of health (SDOH) relate to stage at diagnosis by analyzing data from 4,995 breast cancer survivors i…
View article: Supplemental Figure 1 from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness
Supplemental Figure 1 from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness Open
Supplemental Figure 1: Cell values are predicted means for variables (normalized by square root transformation) used in the latent class model. Predicted means are conditional given classification into a latent class group (listed along th…
View article: Supplemental Table 1 from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness
Supplemental Table 1 from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness Open
Supplemental Table 1: Description of care outcomes evaluated in this study, spanning pre-diagnostic (2x), diagnostic (1x), and post-diagnostic (3x) care.
View article: Supplemental Table 3 from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness
Supplemental Table 3 from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness Open
Supplemental Table 3: Alternate models are shown for delayed and prolonged treatment with stratification (rather than adjustment, as in the main analysis) for patients with stage I, II, or III-IV breast cancer.
View article: Data from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness
Data from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness Open
Background:Geographic disparities in breast cancer outcomes exist. Few studies have examined community- and health system–level factors associated with care timeliness, an important measure of care quality.Methods:The Carolina Breast Cance…
View article: Supplemental Table 2 from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness
Supplemental Table 2 from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness Open
Supplemental Table 2: Summary of statistical fit criteria (including AIC, BIC, SABIC, entropy, and sample size) used to evaluate optimal number of latent class groups
View article: Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness
Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness Open
Background: Geographic disparities in breast cancer outcomes exist. Few studies have examined community- and health system–level factors associated with care timeliness, an important measure of care quality. Methods: The Carolina Breast Ca…
View article: Emotional and functional well-being in long-term breast cancer survivorship
Emotional and functional well-being in long-term breast cancer survivorship Open
View article: Characterizing Cancer Burden in the American Indian Population in North Carolina.
Characterizing Cancer Burden in the American Indian Population in North Carolina. Open
BACKGROUND: The American Indian (AI) population in North Carolina has limited access to the Indian Health Service. Consequently, cancer burden and disparities may differ from national estimates. We describe the AI cancer population and exa…
View article: Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status.
Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status. Open
BACKGROUND: OncotypeDx is a prognostic and predictive genomic assay used in early-stage hormone receptor-positive, HER2- (HR+/HER2-) breast cancer. It is used to inform adjuvant chemotherapy decisions, but not all eligible women receive te…
View article: A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness.
A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness. Open
BACKGROUND: Delays in breast cancer diagnosis and treatment lead to worse survival and quality of life. Racial disparities in care timeliness have been reported, but few studies have examined access at multiple points along the care contin…
View article: A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness
A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness Open
Background Delays in breast cancer diagnosis and treatment lead to worse survival and quality of life. Racial disparities in care timeliness have been reported, but few studies have examined access at multiple points along the care continu…
View article: Capturing catchment area data comprehensively: The North Carolina Cancer Health Assets and Needs Assessment (CHANA) approach
Capturing catchment area data comprehensively: The North Carolina Cancer Health Assets and Needs Assessment (CHANA) approach Open
Background. A key requirement of community outreach and engagement offices within National Cancer Institute-designated cancer centers is to conduct a comprehensive examination of their catchment area’s population, cancer burden, and assets…
View article: Capturing catchment area data comprehensively: The North Carolina Cancer Health Assets and Needs Assessment (CHANA) approach
Capturing catchment area data comprehensively: The North Carolina Cancer Health Assets and Needs Assessment (CHANA) approach Open
Through data-driven efforts like CHANA, cancer centers and the communities they serve can better understand gaps in care and information needs, opportunities, and resources to improve health outcomes, and priorities for new research and pr…
View article: Supplemental Figure S1 from Characterizing Cancer Burden in the American Indian Population in North Carolina
Supplemental Figure S1 from Characterizing Cancer Burden in the American Indian Population in North Carolina Open
Supplemental Figure S1: Standardized incidence estimates per 100k across classifications of American Indian persons
View article: Supplemental Table S2 from Characterizing Cancer Burden in the American Indian Population in North Carolina
Supplemental Table S2 from Characterizing Cancer Burden in the American Indian Population in North Carolina Open
Supplemental Table S2: Comparison of clinical and sociodemographic characteristics across American Indian classifications for persons diagnosed with cancer between 2014-2018
View article: Data from Characterizing Cancer Burden in the American Indian Population in North Carolina
Data from Characterizing Cancer Burden in the American Indian Population in North Carolina Open
Background:The American Indian (AI) population in North Carolina has limited access to the Indian Health Service. Consequently, cancer burden and disparities may differ from national estimates. We describe the AI cancer population and exam…
View article: Data from Characterizing Cancer Burden in the American Indian Population in North Carolina
Data from Characterizing Cancer Burden in the American Indian Population in North Carolina Open
Background:The American Indian (AI) population in North Carolina has limited access to the Indian Health Service. Consequently, cancer burden and disparities may differ from national estimates. We describe the AI cancer population and exam…
View article: Supplemental Table S2 from Characterizing Cancer Burden in the American Indian Population in North Carolina
Supplemental Table S2 from Characterizing Cancer Burden in the American Indian Population in North Carolina Open
Supplemental Table S2: Comparison of clinical and sociodemographic characteristics across American Indian classifications for persons diagnosed with cancer between 2014-2018
View article: Supplemental Table S1 from Characterizing Cancer Burden in the American Indian Population in North Carolina
Supplemental Table S1 from Characterizing Cancer Burden in the American Indian Population in North Carolina Open
Supplemental Table S1: Clinical and sociodemographic characteristics of Non-Hispanic American Indian in PRCDA counties and Non-Hispanic White cancer cases diagnosed between 2014-2018 (n=206,774)
View article: Supplemental Figure S1 from Characterizing Cancer Burden in the American Indian Population in North Carolina
Supplemental Figure S1 from Characterizing Cancer Burden in the American Indian Population in North Carolina Open
Supplemental Figure S1: Standardized incidence estimates per 100k across classifications of American Indian persons
View article: Supplemental Table S1 from Characterizing Cancer Burden in the American Indian Population in North Carolina
Supplemental Table S1 from Characterizing Cancer Burden in the American Indian Population in North Carolina Open
Supplemental Table S1: Clinical and sociodemographic characteristics of Non-Hispanic American Indian in PRCDA counties and Non-Hispanic White cancer cases diagnosed between 2014-2018 (n=206,774)
View article: Supplementary Table S1 from Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status
Supplementary Table S1 from Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status Open
Supplementary Table S1 shows the concordance between clinical assay results for OncotypeDx and in-house research based version.
View article: Supplementary Figure S1 from Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status
Supplementary Figure S1 from Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status Open
Supplementary Figure S1 depicts geographic differences in OncotypeDx testing across the state of North Carolina. It also shows the magnitude of racial disparities by region within the state.
View article: Supplementary Figure S1 from Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status
Supplementary Figure S1 from Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status Open
Supplementary Figure S1 depicts geographic differences in OncotypeDx testing across the state of North Carolina. It also shows the magnitude of racial disparities by region within the state.
View article: Data from Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status
Data from Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status Open
Background:OncotypeDx is a prognostic and predictive genomic assay used in early-stage hormone receptor–positive, HER2− (HR+/HER2−) breast cancer. It is used to inform adjuvant chemotherapy decisions, but n…
View article: Data from Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status
Data from Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status Open
Background:OncotypeDx is a prognostic and predictive genomic assay used in early-stage hormone receptor–positive, HER2− (HR+/HER2−) breast cancer. It is used to inform adjuvant chemotherapy decisions, but n…
View article: Supplementary Table S1 from Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status
Supplementary Table S1 from Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status Open
Supplementary Table S1 shows the concordance between clinical assay results for OncotypeDx and in-house research based version.
View article: Characterizing Cancer Burden in the American Indian Population in North Carolina
Characterizing Cancer Burden in the American Indian Population in North Carolina Open
Background: The American Indian (AI) population in North Carolina has limited access to the Indian Health Service. Consequently, cancer burden and disparities may differ from national estimates. We describe the AI cancer population and exa…
View article: Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status
Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status Open
Background: OncotypeDx is a prognostic and predictive genomic assay used in early-stage hormone receptor–positive, HER2− (HR+/HER2−) breast cancer. It is used to inform adjuvant chemotherapy decisions, but not all eligible women receive te…